Copyright Reports & Markets. All rights reserved.

Global Temporary Total Artificial Heart (TAH) Market Research Report 2021

Request for Sample of this report
Buy now

1 Temporary Total Artificial Heart (TAH) Market Overview

  • 1.1 Product Overview and Scope of Temporary Total Artificial Heart (TAH)
  • 1.2 Temporary Total Artificial Heart (TAH) Segment by Type
    • 1.2.1 Global Temporary Total Artificial Heart (TAH) Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 SynCardia Systems
    • 1.2.3 Others
  • 1.3 Temporary Total Artificial Heart (TAH) Segment by Application
    • 1.3.1 Temporary Total Artificial Heart (TAH) Sales Comparison by Application: (2021-2027)
    • 1.3.2 Dilated Cardiomyopathy
    • 1.3.3 Ischemic Cardiomyopathy
    • 1.3.4 Others
  • 1.4 Global Temporary Total Artificial Heart (TAH) Market Size Estimates and Forecasts
    • 1.4.1 Global Temporary Total Artificial Heart (TAH) Revenue 2016-2027
    • 1.4.2 Global Temporary Total Artificial Heart (TAH) Sales 2016-2027
    • 1.4.3 Temporary Total Artificial Heart (TAH) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Temporary Total Artificial Heart (TAH) Market Competition by Manufacturers

  • 2.1 Global Temporary Total Artificial Heart (TAH) Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Temporary Total Artificial Heart (TAH) Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Temporary Total Artificial Heart (TAH) Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Temporary Total Artificial Heart (TAH) Manufacturing Sites, Area Served, Product Type
  • 2.5 Temporary Total Artificial Heart (TAH) Market Competitive Situation and Trends
    • 2.5.1 Temporary Total Artificial Heart (TAH) Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Temporary Total Artificial Heart (TAH) Players Market Share by Revenue
    • 2.5.3 Global Temporary Total Artificial Heart (TAH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Temporary Total Artificial Heart (TAH) Retrospective Market Scenario by Region

  • 3.1 Global Temporary Total Artificial Heart (TAH) Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Temporary Total Artificial Heart (TAH) Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Temporary Total Artificial Heart (TAH) Market Facts & Figures by Country
    • 3.3.1 North America Temporary Total Artificial Heart (TAH) Sales by Country
    • 3.3.2 North America Temporary Total Artificial Heart (TAH) Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Temporary Total Artificial Heart (TAH) Market Facts & Figures by Country
    • 3.4.1 Europe Temporary Total Artificial Heart (TAH) Sales by Country
    • 3.4.2 Europe Temporary Total Artificial Heart (TAH) Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Temporary Total Artificial Heart (TAH) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Temporary Total Artificial Heart (TAH) Sales by Region
    • 3.5.2 Asia Pacific Temporary Total Artificial Heart (TAH) Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Temporary Total Artificial Heart (TAH) Market Facts & Figures by Country
    • 3.6.1 Latin America Temporary Total Artificial Heart (TAH) Sales by Country
    • 3.6.2 Latin America Temporary Total Artificial Heart (TAH) Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Temporary Total Artificial Heart (TAH) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Temporary Total Artificial Heart (TAH) Sales by Country
    • 3.7.2 Middle East and Africa Temporary Total Artificial Heart (TAH) Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Temporary Total Artificial Heart (TAH) Historic Market Analysis by Type

  • 4.1 Global Temporary Total Artificial Heart (TAH) Sales Market Share by Type (2016-2021)
  • 4.2 Global Temporary Total Artificial Heart (TAH) Revenue Market Share by Type (2016-2021)
  • 4.3 Global Temporary Total Artificial Heart (TAH) Price by Type (2016-2021)

5 Global Temporary Total Artificial Heart (TAH) Historic Market Analysis by Application

  • 5.1 Global Temporary Total Artificial Heart (TAH) Sales Market Share by Application (2016-2021)
  • 5.2 Global Temporary Total Artificial Heart (TAH) Revenue Market Share by Application (2016-2021)
  • 5.3 Global Temporary Total Artificial Heart (TAH) Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 SynCardia
    • 6.1.1 SynCardia Corporation Information
    • 6.1.2 SynCardia Description and Business Overview
    • 6.1.3 SynCardia Temporary Total Artificial Heart (TAH) Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 SynCardia Product Portfolio
    • 6.1.5 SynCardia Recent Developments/Updates
  • 6.2 BiVACOR
    • 6.2.1 BiVACOR Corporation Information
    • 6.2.2 BiVACOR Description and Business Overview
    • 6.2.3 BiVACOR Temporary Total Artificial Heart (TAH) Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 BiVACOR Product Portfolio
    • 6.2.5 BiVACOR Recent Developments/Updates
  • 6.3 CARMAT
    • 6.3.1 CARMAT Corporation Information
    • 6.3.2 CARMAT Description and Business Overview
    • 6.3.3 CARMAT Temporary Total Artificial Heart (TAH) Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 CARMAT Product Portfolio
    • 6.3.5 CARMAT Recent Developments/Updates
  • 6.4 ReinHeart TAH GmbH
    • 6.4.1 ReinHeart TAH GmbH Corporation Information
    • 6.4.2 ReinHeart TAH GmbH Description and Business Overview
    • 6.4.3 ReinHeart TAH GmbH Temporary Total Artificial Heart (TAH) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 ReinHeart TAH GmbH Product Portfolio
    • 6.4.5 ReinHeart TAH GmbH Recent Developments/Updates
  • 6.5 Cleveland Heart
    • 6.5.1 Cleveland Heart Corporation Information
    • 6.5.2 Cleveland Heart Description and Business Overview
    • 6.5.3 Cleveland Heart Temporary Total Artificial Heart (TAH) Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Cleveland Heart Product Portfolio
    • 6.5.5 Cleveland Heart Recent Developments/Updates
  • 6.6 AbioMed
    • 6.6.1 AbioMed Corporation Information
    • 6.6.2 AbioMed Description and Business Overview
    • 6.6.3 AbioMed Temporary Total Artificial Heart (TAH) Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 AbioMed Product Portfolio
    • 6.6.5 AbioMed Recent Developments/Updates
  • 6.7 OregonHeart, Inc.
    • 6.6.1 OregonHeart, Inc. Corporation Information
    • 6.6.2 OregonHeart, Inc. Description and Business Overview
    • 6.6.3 OregonHeart, Inc. Temporary Total Artificial Heart (TAH) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 OregonHeart, Inc. Product Portfolio
    • 6.7.5 OregonHeart, Inc. Recent Developments/Updates

7 Temporary Total Artificial Heart (TAH) Manufacturing Cost Analysis

  • 7.1 Temporary Total Artificial Heart (TAH) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Temporary Total Artificial Heart (TAH)
  • 7.4 Temporary Total Artificial Heart (TAH) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Temporary Total Artificial Heart (TAH) Distributors List
  • 8.3 Temporary Total Artificial Heart (TAH) Customers

9 Temporary Total Artificial Heart (TAH) Market Dynamics

  • 9.1 Temporary Total Artificial Heart (TAH) Industry Trends
  • 9.2 Temporary Total Artificial Heart (TAH) Growth Drivers
  • 9.3 Temporary Total Artificial Heart (TAH) Market Challenges
  • 9.4 Temporary Total Artificial Heart (TAH) Market Restraints

10 Global Market Forecast

  • 10.1 Temporary Total Artificial Heart (TAH) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Temporary Total Artificial Heart (TAH) by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Temporary Total Artificial Heart (TAH) by Type (2022-2027)
  • 10.2 Temporary Total Artificial Heart (TAH) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Temporary Total Artificial Heart (TAH) by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Temporary Total Artificial Heart (TAH) by Application (2022-2027)
  • 10.3 Temporary Total Artificial Heart (TAH) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Temporary Total Artificial Heart (TAH) by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Temporary Total Artificial Heart (TAH) by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    SynCardia Systems
    Others

    Segment by Application
    Dilated Cardiomyopathy
    Ischemic Cardiomyopathy
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    SynCardia
    BiVACOR
    CARMAT
    ReinHeart TAH GmbH
    Cleveland Heart
    AbioMed
    OregonHeart, Inc.

    Buy now